The specific neurobiological factors underlying the reported smoking-related cognitive deficits are not established. However, there are a few of computed tomography (CT) and magnetic resonance (MR)-based studies that suggest the reported neurocognitive deficiencies in smokers may be, in part, mediated by abnormalities in brain morphology, perfusion and/or neurochemistry. The majority of these studies are cross-sectional in design.
